Market Place
Sourcing Support
Curant Selected As Exclusive Specialty Pharmacy For AQNEURSA
30 Sep 2024 //
BUSINESSWIRE
IntraBio hits the ground running with new rare disease launch
30 Sep 2024 //
FIERCE PHARMA
US FDA approves IntraBio`s drug for rare genetic disease
25 Sep 2024 //
REUTERS
IntraBio Announces FDA Accepts NDA for IB1001 for Niemann-Pick Disease Type C
26 Mar 2024 //
ACCESSWIRE
IntraBio NPC Phase III Successful Trial
29 Jun 2023 //
ACCESSWIRE
IntraBio Update
12 Apr 2023 //
ACCESSWIRE
IntraBio Completes Recruitment for IB1001 NPC Pivotal Clinical Trial
08 Dec 2022 //
ACCESSWIRE
IntraBio Reaches Target Enrollment for IB1001 NPC Pivotal Clinical Trial
22 Nov 2022 //
ACCESSWIRE
IntraBio Reports Further Detail On Positive Data From IB1001
14 Sep 2021 //
ACESSWIRE
IntraBio therapy demonstrates significant benefits for GM2
20 Aug 2021 //
MANUFACTURINGCHEMIST
IntraBio Reports Further Detail on Positive Data from IB1001
19 Oct 2020 //
ACCESSWIRE
IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial
30 Sep 2020 //
ACCESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.